Tele-rehabilitation Through CIMT at Recovering the Function of the Upper Limb and Quality of Life
TeleCIMT
Tele-rehabilitation Through Constraint Induced Movement Therapy (TeleCIMT) at Recovering the Function of the Upper Limb and Quality of Life
1 other identifier
interventional
22
1 country
1
Brief Summary
The current pandemic scenario is immensely challenging for healthcare professionals. Telerehabilitation,is a promising option that benefited many people, allowing continuity of therapeutic processes and promoting the admission of people without prior access to rehabilitation programs. This modality has shown comparable results with conventional rehabilitation strategies, applied in patients with neurological pathologies. However, the modalities applied and the quality of the studies are insufficient to establish their real benefits and effectiveness. Strategies such as CIMT, have been shown to be effective in improving upper limb function and restoring quality of life in stroke survivors. However, there is little evidence on its effectiveness when administered under telerehabilitation modality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2021
CompletedFirst Posted
Study publicly available on registry
May 7, 2021
CompletedStudy Start
First participant enrolled
May 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2022
CompletedNovember 9, 2022
November 1, 2022
15 days
April 28, 2021
November 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Upper limb function in patients after stroke.
MAL: It is a structured interview, composed by 30 items, intended to examine how much and how well the subject uses their more-affected arm outside of the laboratory setting. During the test administration. participants should be told that they can give half scores (i.e., 0.5,1.5,2.5,3.5,4.5) if this is reflective of their ratings. ARAT: It is a performance test that evaluates the ability of the affected upper limb to pick up, move and grasp objects of different size, weight and shape in patients with cortical injury. It is composed of 19 items that examine grip, grip, clamp and gross movement. The total score ranges from 0 (none of the movements were performed) to 57 (all the movements were performed without difficulty). The application of both instruments will be carried out virtually according to standardized procedures.
3 weeks
Secondary Outcomes (1)
The quality of life of patients after stroke.
3 weeks.
Study Arms (1)
TeleCIMT group
EXPERIMENTALOne month after baseline evaluations, patients will receive a 3-week program through TeleCIMT. * Task Oriented Repetitive Training * Use of the Affected Upper Extremity * Transfer Package
Interventions
Mode applied remotely, through the principles and components of the CIMT protocol.
Eligibility Criteria
You may qualify if:
- Patients aged between 30 and 80 years.
- Who present a single stroke event confirmed by CT,
- Between 5 and 14 points on the NIHSS Scale
- Who have the ability to sit independently.
- Who can follow simple instructions (score greater than 13 on the Mini Menta)l.
- \<2 points on the Modified Ashworth Scale on elbow and wrist
- \<4 points on the Visual Analog Scale on shoulder.
- That they can perform a functional test of 20 ° of wrist extension and 10 ° of finger extension (take and drop a cloth with the affected hand).
You may not qualify if:
- Severe cognitive impairment (aphasia, attention deficit, reasoning or memory disorders).
- Severe sensory impairment (visual-auditory).
- Orthopedic limitation (use of a cane).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad de La Frontera
Temuco, Chile
Study Officials
- PRINCIPAL INVESTIGATOR
Arlette Doussoulin, PHD
Universidad de La Frontera
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 28, 2021
First Posted
May 7, 2021
Study Start
May 5, 2022
Primary Completion
May 20, 2022
Study Completion
August 30, 2022
Last Updated
November 9, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share
The research team is in talks with their counterpart from the University of Sydney, led by Dr. Lauren Christie, who are developing research on the same topic of study.